10-Q Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001739104-20-000008`
Period End Date	20200331
Filing Date	20200507
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	elan-20200331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 32 Cash Flow Statement 60 Stockholders Equity 19 Comprehensive Income 12

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$6.20M	USD	Point-in-time
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.40M	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$919.70M	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$930.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$334.00M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.21B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$272.10M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowances of $7.4 (2020) and $6.2 (2019)	`AccountsReceivableNetCurrent`	$816.90M	USD	Point-in-time
Accounts receivable, net of allowances of $7.4 (2020) and $6.2 (2019)	`AccountsReceivableNetCurrent`	$676.80M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$73.00M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$66.90M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Inventories (Note 8)	`InventoryNet`	$1.05B	USD	Point-in-time
Inventories (Note 8)	`InventoryNet`	$1.02B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	398.83M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	373.01M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	373.01M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$87.40M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$132.10M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	398.83M	shares	Point-in-time
Receivable from Lilly (Note 16)	`DueFromRelatedPartiesCurrent`	$8.70M	USD	Point-in-time
Receivable from Lilly (Note 16)	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Restricted cash (Note 16)	`RestrictedCashCurrent`	$10.70M	USD	Point-in-time
Restricted cash (Note 16)	`RestrictedCashCurrent`	$28.50M	USD	Point-in-time
Restricted cash (Note 16)	`RestrictedCashCurrent`	$11.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.37B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.12B	USD	Point-in-time
Goodwill	`Goodwill`	$2.99B	USD	Point-in-time
Goodwill	`Goodwill`	$3.00B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.48B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.46B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$217.00M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$185.00M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $919.7 (2020) and $930.5 (2019)	`PropertyPlantAndEquipmentNet`	$955.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $919.7 (2020) and $930.5 (2019)	`PropertyPlantAndEquipmentNet`	$930.10M	USD	Point-in-time
Total assets	`Assets`	$9.73B	USD	Point-in-time
Total assets	`Assets`	$8.99B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$215.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$222.60M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$56.20M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$99.60M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$192.70M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$211.00M	USD	Point-in-time
Current portion of long-term debt (Note 10)	`LongTermDebtCurrent`	$26.00M	USD	Point-in-time
Current portion of long-term debt (Note 10)	`LongTermDebtCurrent`	$24.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$244.40M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$217.60M	USD	Point-in-time
Payable to Lilly (Note 16)	`DueToRelatedPartiesCurrent`	$16.40M	USD	Point-in-time
Payable to Lilly (Note 16)	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$707.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$818.50M	USD	Point-in-time
Long-term debt (Note 10)	`LongTermDebtNoncurrent`	$2.04B	USD	Point-in-time
Long-term debt (Note 10)	`LongTermDebtNoncurrent`	$2.33B	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$82.10M	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$82.50M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$90.20M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$100.80M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$150.30M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$106.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.44B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.07B	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value, 1,000,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value, 1,000,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 398,825,969 and 373,011,513 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 398,825,969 and 373,011,513 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.64B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$6.87B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$33.80M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$84.30M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-173.70M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-242.60M	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.55B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.66B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.99B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$9.73B	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$657.70M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$731.10M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$343.80M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$332.70M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$66.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$64.10M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$181.10M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$182.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$51.60M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$49.00M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$74.80M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$24.90M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$20.80M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$16.50M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-2.60M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-1.10M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$725.50M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$686.30M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$44.80M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-67.80M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-18.70M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$13.30M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-49.10M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$0.09	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	365.70M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	403.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	403.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	366.00M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-49.10M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$81.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.20M	USD	1 Quarter
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$16.30M	USD	1 Quarter
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-25.10M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$11.10M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$7.70M	USD	1 Quarter
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	-	USD	1 Quarter
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$4.00M	USD	1 Quarter
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	$3.80M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$9.80M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$117.20M	USD	1 Quarter
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-500.00K	USD	1 Quarter
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-9.40M	USD	1 Quarter
Net Cash Provided by (Used for) Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$8.10M	USD	1 Quarter
Net Cash Provided by (Used for) Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$4.30M	USD	1 Quarter
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.00M	USD	1 Quarter
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.60M	USD	1 Quarter
Proceeds from settlement of net investment hedges (Note 11)	`ProceedsFromHedgeInvestingActivities`	$25.20M	USD	1 Quarter
Proceeds from settlement of net investment hedges (Note 11)	`ProceedsFromHedgeInvestingActivities`	-	USD	1 Quarter
Purchases of software	`PaymentsForSoftware`	$2.50M	USD	1 Quarter
Purchases of software	`PaymentsForSoftware`	$31.80M	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$500.00K	USD	1 Quarter
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$400.00K	USD	1 Quarter
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.60M	USD	1 Quarter
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-31.00M	USD	1 Quarter
Repayments of borrowings (Note 10)	`RepaymentsOfLongTermLinesOfCredit`	$7.50M	USD	1 Quarter
Repayments of borrowings (Note 10)	`RepaymentsOfLongTermLinesOfCredit`	$371.40M	USD	1 Quarter
Proceeds from issuance of long-term debt (Note 10)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$79.20M	USD	1 Quarter
Proceeds from issuance of long-term debt (Note 10)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	1 Quarter
Proceeds from issuance of common stock and tangible equity units (Note 9)	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Proceeds from issuance of common stock and tangible equity units (Note 9)	`ProceedsFromIssuanceOrSaleOfEquity`	$1.22B	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$3.10M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$175.10M	USD	1 Quarter
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	-	USD	1 Quarter
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-15.20M	USD	1 Quarter
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-156.40M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-12.80M	USD	1 Quarter
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-500.00K	USD	1 Quarter
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-339.50M	USD	1 Quarter
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$896.60M	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-14.50M	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-9.30M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-376.90M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$872.00M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$300.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$300.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$300.60M	USD	Point-in-time

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.55B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$6.66B	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-49.10M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-68.90M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-7.00M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$15.80M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.40M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.10M	USD	1 Quarter
Issuance of stock under employee stock plans, net	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$-12.80M	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$767.50M	USD	1 Quarter
Issuance of tangible equity units, net of issuance costs	`TangibleEquityUnitsIssuedDuringPeriodValue`	$452.40M	USD	1 Quarter
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.55B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$6.66B	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-49.10M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Unrealized loss on derivatives for cash flow hedges, net of taxes	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-39.20M	USD	1 Quarter
Unrealized loss on derivatives for cash flow hedges, net of taxes	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-29.30M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.20M	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$400.00K	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-68.90M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.30M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-118.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.